117 related articles for article (PubMed ID: 2862098)
1. Pharmacologic treatment of dilated cardiomyopathy with special reference to the role of beta-blockers.
Waagstein F
Herz; 1985 Jun; 10(3):143-8. PubMed ID: 2862098
[TBL] [Abstract][Full Text] [Related]
2. Influence of beta-blockade with metoprolol on symptoms and functional capacity of patients with idiopathic dilated cardiomyopathy.
Santostasi G; Marinato PG; Miraglia G; Egloff C; Maragno I
Minerva Cardioangiol; 1994 Dec; 42(12):575-82. PubMed ID: 7753426
[TBL] [Abstract][Full Text] [Related]
3. [Safety and tolerability of beta-blockers in severe cardiac decompensation from dilated cardiomyopathy].
Sinagra G; Perkan A; Zecchin M; Di Lenarda A; Lardieri G; Rakar S; Secoli G; Pinamonti B; Camerini F
G Ital Cardiol; 1995 Oct; 25(10):1255-63. PubMed ID: 8682221
[TBL] [Abstract][Full Text] [Related]
4. [Beta receptor blockers in dilated cardiomyopathy (clinical aspects)].
Sigmund M; Reineke T
Z Kardiol; 1992; 81 Suppl 4():65-70. PubMed ID: 1363261
[TBL] [Abstract][Full Text] [Related]
5. Treatment of cardiac myopathies with beta blockers. What do we know, where do we go from here?
Anderson JL
Postgrad Med; 1988 Feb; Spec No():104-12. PubMed ID: 2894653
[TBL] [Abstract][Full Text] [Related]
6. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of dilated cardiomyopathy with digitalis, diuretics and vasodilators].
Liebau G
Herz; 1985 Jun; 10(3):138-42. PubMed ID: 2991095
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of heart failure with beta-blockers?].
Osterziel KJ; Dietz R
Z Kardiol; 1997 Jan; 86(1):1-8. PubMed ID: 9133118
[TBL] [Abstract][Full Text] [Related]
9. [The use of beta blockers in heart failure: clinical studies].
Cobelli F
Ital Heart J Suppl; 2000 Aug; 1(8):996-1002. PubMed ID: 10993005
[TBL] [Abstract][Full Text] [Related]
10. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: modification by beta receptor blockers--a therapeutic approach?].
Lohmann FW
Herz; 1990 Jun; 15(3):202-6. PubMed ID: 1973915
[TBL] [Abstract][Full Text] [Related]
11. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
12. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
Yokota Y
J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
[TBL] [Abstract][Full Text] [Related]
13. [Chronic treatment of dilated cardiomyopathy by beta blocking agents. Clinical and hemodynamic follow-up].
Cucchini F; Compostella L; Papalia D; de Domenico R; Iavernaro A; Zeppellini R
G Ital Cardiol; 1988 Oct; 18(10):835-42. PubMed ID: 2907743
[TBL] [Abstract][Full Text] [Related]
14. [Value of beta blockers in the treatment of recurrent ventricular tachycardia in cardiac insufficiency].
Hermida JS; Coumel P; Leclercq JF; Cauchemez B; Maison-Blanche P; Leenhardt A; Slama R
Arch Mal Coeur Vaiss; 1987 Mar; 80(3):290-300. PubMed ID: 2887146
[TBL] [Abstract][Full Text] [Related]
15. [Hemodynamics and ventricular function in dilated cardiomyopathies following administration of the new beta-blocker ridazolol].
Haerer W; Henze E; Stauch M
Herz; 1988 Feb; 13(1):54-8. PubMed ID: 2897323
[TBL] [Abstract][Full Text] [Related]
16. Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome.
De Maria R; Di Lenarda A; Gavazzi A; Porcu M; Sinagra G; Parolini M;
Ital Heart J; 2001 Feb; 2(2):130-8. PubMed ID: 11256541
[TBL] [Abstract][Full Text] [Related]
17. [Trends in pharmacological treatment of congestive heart failure].
Halawa B
Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
[TBL] [Abstract][Full Text] [Related]
18. [How the natural history of dilated cardiomyopathy has changed. Review of the Registry of Myocardial Diseases of Trieste].
Di Lenarda A; Pinamonti B; Mestroni L; Salvi A; Sabbadini G; Gregori D; Perkan A; Zecchin M; Carniel E; Bussani R; Silvestri F; Morgera T; Camerini F; Sinagra G
Ital Heart J Suppl; 2004 Apr; 5(4):253-66. PubMed ID: 15185463
[TBL] [Abstract][Full Text] [Related]
19. [How are tachycardic cardiac arrhythmias modified by therapy of congestive heart failure?].
Meinertz T; Hofmann T; Drexler H; Zehender M; Just H
Herz; 1990 Jun; 15(3):207-13. PubMed ID: 2198221
[TBL] [Abstract][Full Text] [Related]
20. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.
Cohn JN; Archibald DG; Francis GS; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Flohr KH
Circulation; 1987 May; 75(5 Pt 2):IV49-54. PubMed ID: 3552302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
